44 Wealth Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.15M Sell
10,188
-4,070
-29% -$876K 0.75% 39
2025
Q4
$2.93M Buy
14,258
+1,981
+16% +$373K 0.98% 23
2025
Q3
$1.93M Sell
12,277
-5,072
-29% -$783K 0.65% 42
2025
Q2
$2.91M Sell
17,349
-1,937
-10% -$287K 1.03% 20
2025
Q1
$2.66M Buy
19,286
+1,304
+7% +$166K 1% 25
2024
Q4
$2.13M Sell
17,982
-1,118
-6% -$131K 0.82% 36
2024
Q3
$2.14M Buy
+19,100
New +$2M 0.75% 35
2023
Q2
$623K Sell
6,584
-74
-1% -$6.25K 0.21% 94
2023
Q1
$503K Buy
6,658
+18
+0.3% +$1.36K 0.17% 109
2022
Q4
$510K Buy
6,640
+1,899
+40% +$144K 0.18% 105
2022
Q3
$316K Buy
+4,741
New +$301K 0.13% 131

Other funds holding CAH

44 Wealth Management's CAH Position: Q1 2026 in Review

44 Wealth Management reduced its Cardinal Health (CAH) stake by 29% in Q1 2026, selling an estimated $876K and leaving 10,188 shares worth $2.15M. The position accounts for 0.75% of the portfolio, ranked #39.

44 Wealth Management first reported a position in CAH in Q3 2022 and has held it in 11 quarters since. The position peaked at $2.93M in Q4 2025. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • 44 Wealth Management held 10,188 shares of Cardinal Health worth $2.15M as of Q1 2026.
  • 44 Wealth Management sold 4,070 Cardinal Health shares in Q1 2026, an estimated $876K.
  • Cardinal Health made up 0.75% of 44 Wealth Management's portfolio in Q1 2026, its #39 holding.
  • 44 Wealth Management first reported a position in Cardinal Health in Q3 2022 and has held it in 11 quarters since.
  • 44 Wealth Management's Cardinal Health position peaked at $2.93M in Q4 2025.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on 44 Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.